ClinicalTrials.govpublic full text
A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
rheumatoid arthritis, fully human anti-tnfa monoclonal antibody, cnto148, golimumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804361
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.